In osteosarcoma patients, lower ASS1 expression levels in tumor samples were associated with resistance to doxorubicin treatment (Kim et al., 2016) and with the development of pulmonary metastases (Kobayashi et al., 2010). Here, ASS1 is linked to neoplasm.